ESR1 and breast cancer: We found that high-level expression of HSP90AA1 independently led to higher risk of death from breast cancer in TNBC, while HSP90AB1 caused poor survival among patients with the HER2-/ER+ breast cancer subtype through increased risk of distant metastasis (Table 2 and Additional file 7).